Literature DB >> 23676597

Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein.

Atsuro Fukuhara1, Yoshinori Tanino, Suguru Sato, Taeko Ishii, Takefumi Nikaido, Kenya Kanazawa, Junpei Saito, Takashi Ishida, Makoto Kanno, Tsuyoshi Watanabe, Mitsuru Munakata.   

Abstract

Myeloperoxidase- and proteinase 3-anti-neutrophil cytoplasmic antibodies (ANCAs) are often negative in cases in which systemic vasculitis is highly suspected. We herein present a case of bactericidal/permeability increasing protein (BPI)-ANCA-positive systemic vasculitis. This case highlights the possible role of BPI-ANCA in the pathogenesis of systemic vasculitis as well as the possible use of BPI as a diagnostic tool. The accumulation of further case-based reports is expected to shed some light on the pathogesis of systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676597     DOI: 10.2169/internalmedicine.52.9477

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

Review 2.  Vasculitis in Cystic Fibrosis.

Authors:  Francesca Sposito; Paul S McNamara; Christian M Hedrich
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

Review 3.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28

4.  Differential Enhancement of Neutrophil Phagocytosis by Anti-Bactericidal/Permeability-Increasing Protein Antibodies.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; Rachel M Wierzbicki; Katherine J Sessions; William F C Rigby
Journal:  J Immunol       Date:  2021-07-16       Impact factor: 5.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.